Title page:

The title page should contain the article title, full name(s) of author(s), highest academic degrees, department(s), institution and the address, e-mail address, telephone and fax numbers of the corresponding author, a running title of not more than 40 characters. Include the address for reprints if different from that of corresponding author.

Abstract:

Abstract should be provided that clearly describes the manuscript in no more than 250 words. Japanese abstract will be added in editorial office in the case of acceptance.

Key words:

Key words are required for indexing and abstracting services up to 5 words.

Text:

All manuscripts must be organized into Introduction, Materials and Methods, Results, Discussion. Abbreviations must be defined immediately following the first appearance in the text. Drug and chemical names should be stated in standard chemical or generic nomenclature. Units of measure should be presented according to the International System (SI) of units. Clinical data may be presented in conventional units with SI in parentheses.

Acknowledgements:

Acknowledgement should be included at the end of the text. If data from other published studies are used, it is the author’s responsibility to obtain permission.

References:

The authors are responsible for the accuracy of the references. References should be numbered consecutively in text in the order of appearance. If there are more than two authors, name only the first two authors and then use et al. Refer to the List of Journal Indexed in Index Medicus for abbreviations of journal names.

Sample references:

Journal article
Ukai K, Higashi JT, et al: Edge-light pupil oscillation of optic neuritis.
Neuro-ophthalmol 1: 33-43, 1980
Book
Hoyt WF, Daroff RB: Supranuclear disorders of ocular control systems in man.
Bach-y-Rita D, Collins CC, et al (eds): The control of eye movements. Academic Press,
New York, 1971, pp 367-390

Tables:

Tables should be typed on separate pages at the end of the manuscript, cited in order in the text, and numbered consecutively with Arabic numerals. Each tables should have a caption typed above the table. Table footnotes should be indicated by superscript lower-case letters.

Figures:

Figures must be cited consecutively in the text, and numbered in the order in which they are discussed with Arabic numerals. Brief legends for each figure should be typed on separate pages. The illustrations should be labeled on the back to indicate (1) the top of the figure, (2) the figure number, (3) the author(s)’ name(s). Figures must be of sufficient size and clarity to allow reduction as necessary to meet layout requirements. Line drawing should be printed on good quality glossy paper. Letters, numbers, symbols in a figure should be clear and of sufficient size so that if the figure must be reduced for publication they will still be legible. Authors are charged for color figures, tracing and reprints.

Page proofs and corrections:

Corresponding authors will receive page proofs to check the copyedited and typeset article before publication. It is the author’s responsibility to ensure that there are no errors in the proofs. Changes that have been made to make the article conform to journal style should be allowed to stand if they do not alter the authors’ meaning. Proofs must be checked carefully and returned within 2 days of receipt, as requested in the cover letter accompanying the page proofs.

Reprints:

Authors will receive a reprint order form with the page proofs that includes reprint costs. Reprint requests should be returned with the corrected proofs. Reprints are normally shipped within 2 months after publication of the issue in which the item appears.

Disc submission:

Final version of the manuscript following decision of acceptance should be submitted in electric/floppy disc (2HD) written with MS word.

Publisher's contact:

To submit the manuscripts and to send corrected page proofs, reprint order forms, and any other related materials, the address is:

ASNOS office c/o: Inouye Eye Hospital, 4-3 Kanda Surugadai, Chiyoda-ku,Tokyo 101-0062, Japan
Phone +81-3-5283-7427, Fax +81-3-5283-7428

Patient anonymity and informed consent:

It is the author’s responsibility to make sure that a patient’s anonymity is protected accurately. Authors should remove patients’ names from figures unless they obtain written consent from the patients and submit written consent with the manuscript. It is also the author’s responsibility to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated.

Declaration of Helsinki:

For research involving human subjects, ASNOS requires that authors state that their research followed the tenets of the Declaration of Helsinki in the Methods section of their manuscript.